Skip to main content
Premium Trial:

Request an Annual Quote

Satoris to Use Xennex Database

NEW YORK (GenomeWeb News) – Satoris will use Xennex's GeneCards database and other tools in its biomarker studies, under a new agreement announced by Xennex today.

The agreement gives Satoris access to GeneCards, which is a searchable integrated database of human genes for use in genomic, proteomic, transcriptomics, and genetic functional information on all known and predicted human genes.

Satoris will use the database in its protein biomarker research. It is seeking markers for neurological diseases such as Alzheimer's, Parkinson's, multiple sclerosis, and diabetic neuropathy.

The agreement also gives Satoris access to related tools and early access to input from the new GeneCards version 3.0 prototype, which is currently "in advanced stages of development," Xennex said.

Financial terms of the agreement were not released.

The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.